Literature DB >> 30044

Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants.

W E Beschorner, R Saral, G M Hutchins, P J Tutschka, G W Santos.   

Abstract

Graft-versus-host disease, a complication of allogeneic bone-marrow transplantation, involves primarily the skin, liver and intestines, but may also be associated with pneumonia. To determine the relation of graft-versus-host disease with pneumonia, we evaluated the autopsies of 59 allogeneic and two autologous recipients and 74 control patients with various pulmonary diseases, who had not received a bone-marrow transplant. Lymphocytic bronchitis, characterized by lymphocyte-associated necrosis of the bronchial mucosa and often the submucosal glands, was present in 12 of 20 patients with Grade 2 or greater graft-versus-host disease but in only three of 39 with Grade 0 to 1 disease (P less than 0.0005). Onset of respiratory disease correlated with the time of onset of graft-versus-host disease. Patients with lymphocytic bronchitis had a higher incidence of bronchopneumonia and acute bronchitis of the lower respiratory tract. Lymphocytic bronchitis did not occur in the controls and appears to be a component of graft-versus-host disease that leads to bronchopneumonia, probably through destruction of the mucociliary apparatus.

Entities:  

Mesh:

Year:  1978        PMID: 30044     DOI: 10.1056/NEJM197811092991902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  24 in total

1.  The pulmonary complications of bone marrow transplantation in adults.

Authors:  P W Noble
Journal:  West J Med       Date:  1989-04

Review 2.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

Review 3.  How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Kirsten M Williams
Journal:  Blood       Date:  2016-11-16       Impact factor: 22.113

Review 4.  Bone marrow transplantation and the lung.

Authors:  P J Hamilton; A D Pearson
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

5.  Histopathology of the lung after bone marrow transplantation.

Authors:  J P Sloane; M H Depledge; R L Powles; G R Morgenstern; B S Trickey; P J Dady
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

6.  Bone marrow transplantation in children.

Authors:  S Storch; S A Feig; R P Gale
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

7.  Bone marrow transplantation in the rat. I. Histologic correlations and quantitation of cellular infiltrates in acute graft-versus-host disease.

Authors:  R Renkonen; P Häyry
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

8.  A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome.

Authors:  Gerhard C Hildebrandt; Krystyna M Olkiewicz; Leigh Corrion; Shawn G Clouthier; Elizabeth M Pierce; Chen Liu; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

9.  Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease.

Authors:  Barbara Érsek; Nikolett Lupsa; Péter Pócza; Anett Tóth; Andor Horváth; Viktor Molnár; Bence Bagita; András Bencsik; Hargita Hegyesi; András Matolcsy; Edit I Buzás; Zoltán Pós
Journal:  Cell Mol Life Sci       Date:  2016-04-30       Impact factor: 9.261

Review 10.  Acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  C Perreault; M Gyger; J Boileau; Y Bonny; S Cousineau; M Lacombe; R Lavallee; E Tawil; G D'Angelo
Journal:  Can Med Assoc J       Date:  1983-11-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.